{"accidental exposure to product": 6.78, "activated partial thromboplastin time prolonged": 4.77, "adverse drug reaction": 2.17, "anaemia": 7.64, "analgesic therapy": 52.68, "anti-erythropoietin antibody negative": 160.07, "anti-erythropoietin antibody positive": 625.13, "aortic stenosis": 7.64, "aplasia pure red cell": 340.74, "aplastic anaemia": 7.53, "appendicitis": 9.3, "appendicolith": 790.14, "arteriovenous fistula thrombosis": 55.49, "ascites": 3.97, "azotaemia": 11.07, "bacterial infection": 4.89, "blood iron decreased": 3.99, "blood parathyroid hormone increased": 14.36, "blood phosphorus increased": 34.24, "blood product transfusion dependent": 46.59, "blood test abnormal": 5.7, "blood uric acid increased": 9.4, "bone marrow disorder": 9.12, "bone marrow failure": 20.01, "calciphylaxis": 27.75, "cardiogenic shock": 8.95, "cerebrovascular accident": 2.08, "colon cancer": 2.31, "complications of transplanted kidney": 16.36, "death": 15.69, "dementia": 2.39, "device difficult to use": 99.73, "device issue": 4.67, "dialysis": 126.94, "diverticulum": 4.62, "drug dose omission by device": 15.67, "drug specific antibody": 19.01, "drug specific antibody absent": 261.76, "end stage renal disease": 5.24, "eosinophilia": 3.74, "fall": 2.5, "fluid retention": 3.07, "full blood count abnormal": 4.33, "gastric haemorrhage": 3.39, "general physical health deterioration": 2.1, "gout": 2.92, "haematocrit decreased": 4.23, "haemodialysis": 338.17, "haemoglobin abnormal": 86.15, "haemoglobin decreased": 18.24, "haemoglobin increased": 27.58, "hip fracture": 8.49, "hospitalisation": 46.93, "hyperparathyroidism": 30.26, "hyperphosphataemia": 20.99, "hypervolaemia": 6.51, "hypocalcaemia": 3.55, "hyponatraemia": 2.23, "hypophosphataemia": 3.74, "incorrect dose administered by device": 3.16, "incorrect route of product administration": 2.4, "infection": 2.34, "injection site bruising": 3.15, "injection site haemorrhage": 7.82, "iron deficiency": 19.62, "kidney infection": 3.21, "kidney transplant rejection": 5.54, "laboratory test abnormal": 4.05, "leukocytosis": 2.47, "localised infection": 3.01, "lower respiratory tract infection": 4.4, "lung neoplasm malignant": 2.49, "myelodysplastic syndrome": 18.96, "myelodysplastic syndrome with single lineage dysplasia": 137.31, "needle issue": 3.9, "neoplasm malignant": 4.75, "neutralising antibodies positive": 75.43, "non-neutralising antibodies positive": 654.45, "normochromic normocytic anaemia": 13.26, "pancytopenia": 3.12, "peritoneal dialysis": 198.94, "peritonitis": 9.5, "plasma cell myeloma": 2.57, "platelet count abnormal": 3.97, "polycythaemia": 8.33, "premature baby": 4.05, "premature delivery": 4.82, "product storage error": 7.9, "rash maculo-papular": 2.41, "red blood cell count decreased": 3.1, "rehabilitation therapy": 24.0, "renal disorder": 5.76, "renal failure": 2.29, "renal impairment": 2.76, "renal transplant": 83.37, "reticulocyte count abnormal": 134.56, "reticulocyte count decreased": 190.68, "reticulocytopenia": 134.56, "sepsis": 2.44, "serum ferritin increased": 5.93, "skin ulcer": 2.27, "splenomegaly": 4.06, "staphylococcal infection": 2.16, "surgery": 3.48, "terminal state": 31.57, "therapeutic product effect decreased": 4.18, "therapeutic response decreased": 37.14, "therapy non-responder": 6.86, "toxic skin eruption": 2.95, "transfusion": 27.51, "transplant": 156.41, "transplant rejection": 3.32, "unevaluable event": 7.16, "wrong technique in product usage process": 2.79}